314 related articles for article (PubMed ID: 14501584)
21. Orphan nuclear receptors find a home in the arterial wall.
Laffitte BA; Tontonoz P
Curr Atheroscler Rep; 2002 May; 4(3):213-21. PubMed ID: 11931719
[TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferator-activated receptor-gamma in macrophage lipid homeostasis.
Lee CH; Evans RM
Trends Endocrinol Metab; 2002 Oct; 13(8):331-5. PubMed ID: 12217489
[TBL] [Abstract][Full Text] [Related]
23. Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis.
Neve BP; Fruchart JC; Staels B
Biochem Pharmacol; 2000 Oct; 60(8):1245-50. PubMed ID: 11007963
[TBL] [Abstract][Full Text] [Related]
24. PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway.
Chinetti G; Lestavel S; Bocher V; Remaley AT; Neve B; Torra IP; Teissier E; Minnich A; Jaye M; Duverger N; Brewer HB; Fruchart JC; Clavey V; Staels B
Nat Med; 2001 Jan; 7(1):53-8. PubMed ID: 11135616
[TBL] [Abstract][Full Text] [Related]
25. Peroxisome proliferator-activated receptors in atherosclerosis and inflammation--an update.
Elangbam CS; Tyler RD; Lightfoot RM
Toxicol Pathol; 2001; 29(2):224-31. PubMed ID: 11421489
[TBL] [Abstract][Full Text] [Related]
26. Peroxisome proliferator-activated receptor-alpha enhances lipid metabolism in a skin equivalent model.
Rivier M; Castiel I; Safonova I; Ailhaud G; Michel S
J Invest Dermatol; 2000 Apr; 114(4):681-7. PubMed ID: 10733673
[TBL] [Abstract][Full Text] [Related]
27. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors with functions in the vascular wall.
Chinetti G; Fruchart JC; Staels B
Z Kardiol; 2001; 90 Suppl 3():125-32. PubMed ID: 11374025
[TBL] [Abstract][Full Text] [Related]
28. Modulation of vascular inflammation by PPARs.
Tham DM; Wang YX; Rutledge JC
Drug News Perspect; 2003 Mar; 16(2):109-16. PubMed ID: 12792672
[TBL] [Abstract][Full Text] [Related]
29. Roles of peroxisome proliferator-activated receptor delta in skeletal muscle function and adaptation.
Fredenrich A; Grimaldi PA
Curr Opin Clin Nutr Metab Care; 2004 Jul; 7(4):377-81. PubMed ID: 15192438
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional regulation of human CYP27 integrates retinoid, peroxisome proliferator-activated receptor, and liver X receptor signaling in macrophages.
Szanto A; Benko S; Szatmari I; Balint BL; Furtos I; Rühl R; Molnar S; Csiba L; Garuti R; Calandra S; Larsson H; Diczfalusy U; Nagy L
Mol Cell Biol; 2004 Sep; 24(18):8154-66. PubMed ID: 15340076
[TBL] [Abstract][Full Text] [Related]
31. Nuclear receptor mediated mechanisms of macrophage cholesterol metabolism.
Nagy ZS; Czimmerer Z; Nagy L
Mol Cell Endocrinol; 2013 Apr; 368(1-2):85-98. PubMed ID: 22546548
[TBL] [Abstract][Full Text] [Related]
32. The peroxisome proliferator-activated receptor(PPARgamma) as a regulator of monocyte/macrophage function.
Ricote M; Huang JT; Welch JS; Glass CK
J Leukoc Biol; 1999 Nov; 66(5):733-9. PubMed ID: 10577502
[TBL] [Abstract][Full Text] [Related]
33. Nuclear receptors in macrophages: a link between metabolism and inflammation.
Szanto A; Roszer T
FEBS Lett; 2008 Jan; 582(1):106-16. PubMed ID: 18022390
[TBL] [Abstract][Full Text] [Related]
34. The role of oxidized low-density lipoprotein in the activation of peroxisome proliferator-activated receptor gamma: implications for atherosclerosis.
Wolf G
Nutr Rev; 1999 Mar; 57(3):88-91. PubMed ID: 10101923
[TBL] [Abstract][Full Text] [Related]
35. CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors.
Chinetti G; Gbaguidi FG; Griglio S; Mallat Z; Antonucci M; Poulain P; Chapman J; Fruchart JC; Tedgui A; Najib-Fruchart J; Staels B
Circulation; 2000 May; 101(20):2411-7. PubMed ID: 10821819
[TBL] [Abstract][Full Text] [Related]
36. Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: effects on lipid homeostasis, inflammation, and atherosclerosis.
Ricote M; Valledor AF; Glass CK
Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):230-9. PubMed ID: 14592855
[TBL] [Abstract][Full Text] [Related]
37. [Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control].
Bocher V; Chinetti G; Fruchart JC; Staels B
J Soc Biol; 2002; 196(1):47-52. PubMed ID: 12134632
[TBL] [Abstract][Full Text] [Related]
38. Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein.
Ricote M; Huang J; Fajas L; Li A; Welch J; Najib J; Witztum JL; Auwerx J; Palinski W; Glass CK
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7614-9. PubMed ID: 9636198
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional repression of atherogenic inflammation: modulation by PPARdelta.
Lee CH; Chawla A; Urbiztondo N; Liao D; Boisvert WA; Evans RM; Curtiss LK
Science; 2003 Oct; 302(5644):453-7. PubMed ID: 12970571
[TBL] [Abstract][Full Text] [Related]
40. Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-gamma.
Inoue M; Itoh H; Tanaka T; Chun TH; Doi K; Fukunaga Y; Sawada N; Yamshita J; Masatsugu K; Saito T; Sakaguchi S; Sone M; Yamahara Ki ; Yurugi T; Nakao K
Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):560-6. PubMed ID: 11304473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
